| Permissive hypercapnia for the prevention of morbidity and mortality in mechanically ventilated newborn infants |
| Perphenazine for schizophrenia |
| Perphenazine versus low-potency first-generation drugs for schizophrenia |
| Persistence of immunoglobulin G after natural infection with SARS-CoV-2 |
| Personal assistance for adults (19-64) with both physical and intellectual impairments |
| Personal assistance for older adults without dementia |
| Personal protective equipment for preventing asbestos exposure in workers |
| Personalised interventions for children with conduct problems |
| Personalised risk communication for informed decision making about taking screening tests |
| Personally tailored activities for people with dementia in long-term care |
| Personally tailored activities for people with dementia living in their own homes |
| Pessaries (mechanical devices) for managing pelvic organ prolapse in women |
| Pet allergen control measures for allergic asthma in children and adults |
| PET-CT scanning to assess the spread of non-small cell lung cancer within the chest |
| PETTICOAT technique versus standard TEVAR for complicated type B aortic dissection |
| Pharmaceutical heroin for heroin maintenance in chronic heroin dependents |
| Pharmaceutical policies: effects of policies that determine which drugs are reimbursed |
| Pharmaceutical policies: effects of sales and dispensing policies |
| Pharmaceutical policies: effects on rational drug use |
| Pharmacies might be able to support people with their depression medicines |
| Pharmacist-led interventions for adults with asthma or COPD |
| Pharmacists play vital role in improving patient health shows biggest review of evidence to date |
| Pharmacists providing prescribing advice and education to healthcare professionals in community, primary care and outpatient settings |
| Pharmacologic and radiotherapeutic interventions for advanced pancreatic cancer |
| Pharmacologic interventions for pregnant women enrolled in alcohol treatment programs |
| Pharmacologic interventions for preventing and treating periprosthetic osteoporosis following total hip arthroplasty |
| Pharmacologic therapies for perioperative cerebral protection against neurologic or neurocognitive deficits |
| Pharmacological agents as symptomatic treatment for memory disorder in people with multiple sclerosis |
| Pharmacological and non-pharmacological interventions for symptomatic gastroparesis |
| Pharmacological and non-pharmacological treatments for impulsive-compulsive behaviors in Parkinson's disease |
| Pharmacological and psychological interventions for depression in people with tuberculosis |
| Pharmacological and psychosocial interventions for night eating syndrome in adults |
| Pharmacological anticoagulation and mechanical compression versus mechanical compression alone for venous thromboembolism prophylaxis for post-operative neurosurgical patients |
| Pharmacological interventions for acute and transient psychotic disorder (ATPD) |
| Pharmacological interventions for ADHD symptoms in children with fetal alcohol spectrum disorders (FASD) |
| Pharmacological interventions for adjustment disorders in adults |
| Pharmacological interventions for avoidant personality disorder |
| Pharmacological interventions for benzodiazepine mono-dependence management in outpatient settings |
| Pharmacological interventions for bone health in people with epilepsy |
| Pharmacological interventions for clozapine-induced sinus tachycardia |
| Pharmacological interventions for depression in adults with chronic hepatitis B or C |
| Pharmacological interventions for depression in people with traumatic brain injury |
| Pharmacological interventions for drug-using offenders |
| Pharmacological interventions for epilepsy in people with intellectual disability |
| Pharmacological interventions for hypertensive emergencies |
| Pharmacological interventions for improving respiratory symptoms and function in amyotrophic lateral sclerosis |
| Pharmacological interventions for jet lag |
| Pharmacological interventions for obsessive-compulsive personality disorder |
| Pharmacological interventions for pain in patients with temporomandibular disorders |
| Pharmacological interventions for painful persistent temporomandibular disorders (TMD) |
| Pharmacological interventions for paranoid personality disorder |
| Pharmacological interventions for people with histrionic personality disorder |
| Pharmacological interventions for people with narcissistic personality disorder |
| Pharmacological interventions for preventing bone density loss in critically ill people |
| Pharmacological interventions for preventing clotting of extracorporeal circuits during continuous renal replacement therapy |
| Pharmacological interventions for preventing complications in idiopathic hypercalciuria |
| Pharmacological interventions for preventing contrast-induced nephropathy |
| Pharmacological interventions for preventing recurrent urinary stones in adults and children |
| Pharmacological interventions for preventing salivary gland dysfunction following radiotherapy |
| Pharmacological interventions for reducing weight gain in schizophrenia |
| Pharmacological interventions for reduction of weight gain in people with schizophrenia |
| Pharmacological interventions for schizoid personality disorder |
| Pharmacological interventions for schizotypal personality disorder |
| Pharmacological interventions for self‐harm in adults |
| Pharmacological interventions for the acute management of hyperkalaemia in adults |
| Pharmacological interventions for the prevention and treatment of radiation colitis, enteritis and proctitis |
| Pharmacological interventions for the prevention of pain during endotracheal suctioning in ventilated neonates |
| Pharmacological interventions for the primary prevention of gallbladder stones in adults |
| Pharmacological interventions for the treatment of anxiety disorders in chronic obstructive pulmonary disease |
| Pharmacological interventions for the treatment of aortic root and heart valve disease |
| Pharmacological interventions for the treatment of bleeding in people treated for blunt force or penetrating injury in an emergency department: a systematic review and network meta-analysis |
| Pharmacological interventions for treating acute heterotopic ossification |
| Pharmacological interventions for treating dyslipidemia in patients with HIV infection |
| Pharmacological interventions for treating heart failure in patients with Chagas cardiomyopathy |
| Pharmacological interventions for vasoplegic syndrome after cardiac surgery |
| Pharmacological interventions show potential for a protective role against ischaemia-reperfusion injury in liver resections |
| Pharmacological interventions to decrease ischaemia reperfusion injury in liver transplantation |
| Pharmacological interventions to prevent and treat upper gastrointestinal bleeding in neonates |
| Pharmacological interventions to treat adults with cancer-related fatigue |
| Pharmacological therapies for fibromyalgia (fibromyalgia syndrome) in adults - an overview of Cochrane Reviews |
| Pharmacological therapies for maintenance treatments of opium dependence |
| Pharmacological therapies for the prevention of fractures in men |
| Pharmacological treatment (drugs) for Buerger's disease |
| Pharmacological treatment for aphasia following stroke |
| Pharmacological treatment for chronic central neuropathic pain in people with multiple sclerosis |
| Pharmacological treatment for continuous spike-wave during slow wave sleep syndrome and Landau-Kleffner syndrome |
| Pharmacological treatment for Kleine-Levin syndrome |
| Pharmacological treatment for muscle weakness and wasting in myotonic dystrophy |
| Pharmacological treatment for psychotic depression |
| Pharmacological treatment of depression in people with a primary brain tumour |
| Pharmacological treatments for adults with overweight and obesity without diabetes |
| Pharmacological treatments for chronic fatigue syndrome in adults |
| Pharmacological treatments for chronic hepatitis B liver disease: a network meta-analysis |
| Pharmacological treatments for chronic hepatitis C liver disease: a network meta-analysis |
| Pharmacological treatments for disordered and problem gambling |
| Pharmacological treatments for fatigue associated with palliative care |
| Pharmacological treatments for Friedreich ataxia |
| Pharmacological treatments for low back pain in adults: an overview of Cochrane Reviews |
| Pharmacological treatments for osteoporosis in patients with chronic kidney disease |
| Pharmacological treatments for psychosis-related polydipsia |
| Pharmacological treatments for vaccine-induced immune thrombocytopenia and thrombosis (VITT) after COVID-19 vaccination |
| Pharmacological treatments in panic disorder in adults: a network meta-analysis |
| Pharmacological treatments in panic disorder in adults: a network meta-analysis |
| Pharmacological treatments in panic disorder in adults: a network meta-analysis |
| Pharmacological treatments of postural hypotension |
| Pharmacological, non-invasive brain stimulation and psychological interventions for treating depression after stroke |
| Pharmacomechanical thrombectomy for iliofemoral deep vein thrombosis |
| Pharmacotherapy for Behcet's syndrome |
| Pharmacotherapy for bipolar disorder in older people |
| Pharmacotherapy for hypertension in adults 60 years or older |
| Pharmacotherapy for hypertension in adults with obstructive sleep apnea |
| Pharmacotherapy for resistant hypertension in adults |
| Pharmacotherapy for smoking cessation: effects by subgroup defined by genetically informed biomarkers |
| Pharmacotherapy for tooth grinding or clenching during the sleep (sleep bruxism) |
| Pharmacotherapy for weight loss in adults with type 2 diabetes mellitus |
| Pharyngeal instillation of surfactant before the first breath for prevention of morbidity and mortality in preterm infants at risk of respiratory distress syndrome |
| Phenobarbital prior to preterm birth for preventing neonatal periventricular haemorrhage |
| Phenobarbitone versus phenytoin monotherapy (single-drug treatment) for epilepsy |
| Phenytoin for neuropathic pain and fibromyalgia in adults |
| Phlebotomy for hereditary haemochromatosis |
| Phlebotonics for haemorrhoids |
| Phonics training for English-speaking poor readers |
| Phosphate binders to prevent complications of chronic kidney disease |
| Phosphodiasterase III inhibitors for chronic asthma |
| Phosphodiesterase 4 inhibitors for psoriatic arthritis |
| Phosphodiesterase 5 (sildenafil) inhibitors for pulmonary hypertension |
| Phosphodiesterase III inhibitor class drugs taken orally and long term are associated with increased deaths in heart failure |
| Phosphodiesterase inhibitors for erectile dysfunction in patients with diabetes mellitus |
| Phosphodiesterase inhibitors for treatment of urinary problems in men with benign prostatic hyperplasia |
| Phosphodiesterase type 5 inhibitor plus endothelin receptor antagonist compared to either alone for group 1 pulmonary arterial hypertension |
| Phosphodiesterase-4 inhibitors for people with chronic obstructive pulmonary disease (COPD) |
| Photodynamic therapy for recurrent respiratory papillomatosis |
| Photodynamic therapy for treating age-related macular degeneration |
| Photorefractive keratectomy (PRK) versus laser assisted in situ keratomileusis (LASIK) for correction of long-sightedness |
| Phototherapy for treating foot ulcers in people with diabetes |
| Phototherapy for treating pressure ulcers |
| Phyllanthus species for chronic hepatitis B virus infection |
| Phyllanthus species versus antiviral drugs for chronic hepatitis B virus infection |
| Physical activity and exercise for chronic pain in adults - an overview of Cochrane Reviews |
| Physical activity for improving cognition in older people with mild cognitive impairment |
| Physical activity for improving the symptoms of attention deficit hyperactivity disorder in children and adolescents |
| Physical activity for lower urinary tract symptoms due to benign prostatic obstruction |
| Physical activity for preventing or managing osteoporosis in men |
| Physical activity for the management of cancer-related fatigue in adults |
| Physical activity for women with breast cancer who have completed active cancer treatment |
| Physical activity interventions and nutrition-based interventions for children and adolescents with type 1 diabetes mellitus |
| Physical activity interventions for people with congenital heart disease |
| Physical activity interventions for the physical and mental health of people during and after treatment for bowel cancer |
| Physical activity programs for older adults |
| Physical activity programs for promoting bone mineralization and growth in preterm infants |
| Physical activity to improve exercise capacity in people with cystic fibrosis |
| Physical conditioning as part of a return to work strategy to reduce sickness absence for workers with back pain |
| Physical environmental designs in residential care to improve quality of life of older people |
| Physical examination for the diagnosis of lumbar radiculopathy due to disc herniation in patients with low-back pain and sciatica: a systematic review. |
| Physical exercise as a treatment for sleep problems in older people |
| Physical exercise for oppositional defiant disorder and conduct disorder in children and adolescents |
| Physical exercise for people with Parkinson's disease: what type of exercise works best? |
| Physical exercise for type 1 diabetes mellitus |
| Physical exercise helps to improve symptoms of Parkinson’s Disease |
| Physical exercise training for people with spinal muscular atrophy type 3 |
| Physical exercise training interventions for children and young adults during and after treatment for childhood cancer |
| Physical exercise training to increase cardiorespiratory fitness in people with spinal cord injury |
| Physical fitness training for people with spinal cord injury |
| Physical fitness training for stroke survivors |
| Physical health care monitoring for people with serious mental illness |
| Physical interventions (orthoses, splints, exercise and manual therapy) for treating plantar heel pain |
| Physical interventions for breathlessness in adults with advanced diseases |
| Physical interventions for preventing stress fractures of the lower limbs |
| Physical medicine modalities for mechanical neck disorders |
| Physical methods for preventing deep vein thrombosis in stroke |
| Physical methods for treating fever in children |
| Physical rehabilitation approaches for recovery of function, balance and walking after stroke |
| Physical rehabilitation for older people in long-term care |
| Physical tests for diagnosing anterior cruciate ligament rupture |
| Physical tests for shoulder impingement in primary care |
| Physical therapies for postural abnormalities in people with cystic fibrosis |
| Physical therapies for reducing and controlling lymphoedema of the limbs |
| Physical therapy for the management of patients with temporomandibular disorders and related pain. |
| Physical therapy interventions for pelvic girdle pain (PGP) after pregnancy |
| Physical therapy interventions for the prevention of fractures after spinal cord injury |
| Physical training for asthma |
| Physical treatment interventions for managing spasticity after stroke |
| Physical treatments for idiopathic facial paralysis |
| Physician anaesthetists versus nurse anaesthetists for surgical patients |
| Physician use of red flags to screen for cancer in patients with new back pain |
| Physician use of red flags to screen for fractured vertebrae for patients with new back pain |
| Physicians can be assisted in their delivery of preventive care services through group education, reminder devices and changes to the organisation of care |
| Physiological track-and-trigger/early warning systems for use in maternity care |
| Physiotherapeutic mechanisms for prevention of deep vein thrombosis in patients at risk of haemorrhage |
| Physiotherapy and physiotherapeutical modalities for lateral epicondylitis |
| Physiotherapy for ankylosing spondylitis |
| Physiotherapy for the treatment of Parkinson's disease |
| Physiotherapy for treatment of Parkinson's disease |
| Phytoestrogens for vasomotor menopausal symptoms |
| Phytoestrogens in the treatment of postmenopausal osteoporosis |
| Phytomedicines (medicines derived from plants) for sickle cell disease |
| Piggy-back method versus standard method of liver transplantation |
| Pilates for low back pain |
| Pimozide for schizophrenia or related psychoses |
| Pimozide is an effective treatment for tics in Tourette Syndrome. |
| Pioglitazone for adults with high risk of developing type 2 diabetes mellitus |
| Pioglitazone for people with impaired glucose tolerance or impaired fasting blood glucose |
| Pioglitazone for type 2 diabetes mellitus |
| Piracetam for acute ischaemic stroke |
| Piracetam for fetal distress in labour |
| Piracetam for reducing the incidence of painful sickle cell disease crises |
| Piribedil for levodopa-induced complications in Parkinson's disease |
| Piribedil for symptomatic management of Parkinson's disease |
| Piribedil versus levodopa in early Parkinson's disease |
| Piroxicam as a single dose in treating acute postoperative pain |
| Pitavastatin for lowering lipids |
| Pivotal Response Treatment for autism spectrum disorder (ASD) |
| Placebo interventions for all clinical conditions |
| Placebo response and remission rates in randomised trials of induction and maintenance therapy for Crohn’s disease |
| Placebo response and remission rates in randomised trials of induction and maintenance therapy for ulcerative colitis |
| Placebo versus no treatment for people with schizophrenia |
| Placenta delivery at caesarean section |
| Placental cord drainage after vaginal delivery as part of the management of the third stage of labour |
| Planned abortion after three months of pregnancy can be done using several medicines. This review looked at which medical procedure is the best. |
| Planned birth at or near term for improving health outcomes for pregnant women with pre-existing diabetes and their infants |
| Planned birth at or near term for pregnant women with gestational diabetes and their infants |
| Planned caesarean section for a twin pregnancy |
| Planned caesarean section for term breech delivery |
| Planned caesarean section versus planned vaginal birth for severe pre-eclampsia |
| Planned elective repeat caesarean section versus planned vaginal birth for women with a previous caesarean birth |
| Planned home versus hospital care for rupture of the membranes before 37 weeks' gestation |
| Planned hospital birth versus planned home birth |
| Planned relaparotomy versus relaparotomy on demand for treatment of secondary peritonitis |
| Plasma exchange for chronic inflammatory demyelinating polyradiculoneuropathy |
| Plasma exchange for generalised myasthenia gravis |
| Plasma exchange for Guillain-Barré syndrome |
| Plasma exchange for multiple sclerosis |
| Plasma expanders for people with cirrhosis and large ascites treated with abdominal paracentesis |
| Plasma transfusion strategies for critically ill patients |
| Plasma transfusion to prevent intraventricular haemorrhage in very preterm infants |
| Plasma transfusions before major surgery (other than heart surgery) or invasive procedures, to prevent bleeding |
| Plasma transfusions prior to insertion of central lines for people with abnormal coagulation |
| Plasma transfusions prior to insertion of lumbar puncture needles for people with abnormal coagulation |
| Plasma volume expansion for suspected impaired fetal growth |
| Plasma volume expansion for treatment of pre-eclampsia |
| Plasmakinetic resection versus transurethral resection of the prostate for benign prostatic hyperplasia |
| Plastic stents versus fully covered self-expandable metallic stents for biliary tract strictures in adults with non-cancerous bile duct lesions |
| Plastic stents versus metal stents for endoscopic ultrasound-guided transmural drainage of pancreatic fluid collections |
| Platelet count, spleen length, and platelet-to-spleen length ratio for the diagnosis of oesophageal varices in people with liver disease |
| Platelet glycoprotein IIb/IIIa blockers during percutaneous coronary intervention and as the initial treatment of acute coronary syndromes |
| Platelet rich therapies for long bone healing in adult |
| Platelet transfusion before surgery for people with low platelet counts |
| Platelet transfusion thresholds for thrombocytopenic infants |
| Platelet transfusions are used to prevent bleeding in patients with low platelet counts due to treatment-induced bone marrow failure |
| Platelet transfusions are used to prevent bleeding in people with low platelet counts due to treatment-induced bone marrow failure |
